US drugmaker Imagenetix says it will launch a nationwide retail branding program for its proprietary products. The first to be included will be its Celadrin-based joint health formulas.
The firm's new brand name - Inflame Away - will be exclusively marketed by Imagenetix and sold directly to leading mass market retailers nationwide. The retail branding program will be led by two former executives of Pharmavite Corp, a manufacturer and marketer of vitamins and nutritional supplements.
This article is accessible to registered users, to continue reading please register for free. A free trial will give you access to exclusive features, interviews, round-ups and commentary from the sharpest minds in the pharmaceutical and biotechnology space for a week. If you are already a registered user please login. If your trial has come to an end, you can subscribe here.
Login to your accountTry before you buy
7 day trial access
Become a subscriber
Or £77 per month
The Pharma Letter is an extremely useful and valuable Life Sciences service that brings together a daily update on performance people and products. It’s part of the key information for keeping me informed
Chairman, Sanofi Aventis UK
Copyright © The Pharma Letter 2024 | Headless Content Management with Blaze